ClearPoint Neuro, Inc. (CLPT) Misses Q2 EPS by 1c

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Rothschild Redburn Upgrades Apple (AAPL) to Buy
• Wells Fargo Starts Huntington Bancshares (HBAN) at Overweight